Anixa Biosciences (NASDAQ:ANIX) is a clinical stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company’s vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer--specifically triple negative breast cancer (TNBC), the most lethal form of the disease--as well as a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer. Anixa's unique business model of partnering with world-renowned research institutions on clinical development allows the company to continually examine emerging technologies in complementary fields for further development and commercialization.
View Top Employees from Anixa Biosciences, Inc.Website | http://www.anixa.com |
Ticker | ITUS |
Revenue | $1 million |
Employees | 12 (5 on RocketReach) |
Founded | 1982 |
Address | 3150 Almaden Expy Suite 250, San Jose, California 95118, US |
Phone | (408) 708-9808 |
Technologies |
JavaScript,
HTML,
Google Analytics
+11 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Other Commercial Services, Patent Monetization, Business Services, Patent Assertion |
Competitors | Acacia Research, Amphion Innovations, Elegant Infotech, Entegrion, Inc., MultiplexDX International |
SIC | SIC Code 357 Companies, SIC Code 35 Companies |
NAICS | NAICS Code 541712 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Anixa Biosciences, Inc. employee's phone or email?
The Anixa Biosciences, Inc. annual revenue was $1 million in 2024.
5 people are employed at Anixa Biosciences, Inc..
Anixa Biosciences, Inc. is based in San Jose, California.
The NAICS codes for Anixa Biosciences, Inc. are [541712, 541, 541711, 54, 5417, 54171].
The SIC codes for Anixa Biosciences, Inc. are [357, 35].